Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BSX | ABT |
|---|---|---|
| Price | $44.82 | $101.56 |
| Change today | ▲ 0.45% | ▼ 1.86% |
| Market cap | $64.95B | $175.74B |
| Return, 3 months | +0.8% | +13.0% |
| Return, year to date | -53.0% | -17.4% |
| Return, 1 year | -54.3% | -22.4% |
| P/E (TTM) | 18.1 | 32.9 |
| P/B | 2.6 | 3.4 |
| P/E percentile vs own 5y | 0th | 69th |
| Dividend yield | – | 2.40% |
| Revenue growth (YoY, latest qtr) | +7.5% | +13.0% |
| Net profit growth (YoY) | +13.8% | -47.8% |
| Gross margin | 69.9% | 56.6% |
| Operating margin | 21.0% | 15.8% |
| Net margin | 17.5% | 11.6% |
| Return on equity | 15.5% | 10.7% |
| Analyst target vs. price | +34.1% | +22.4% |
| Analyst buy share | 90% | 100% |
| RSI (14) | 46 | 43 |
| 30-day volatility | 40.3% | 20.1% |
| Max drawdown, 1 year | -59.4% | -38.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.